TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

foobar

Author:
Ellen Leventry
Publish date:
Dec 27, 1998 12:08 AM EST
By
Ellen Leventry
Dynavax Shares Fall on FDA Rejection of Hepatitis B Vaccine
LATEST NEWS

As COVID Shots Get Supply Boost, Will Enough Americans Take Them?

  • By Adam Smith
k-1 Tax Form
Sponsored Story

What is a Schedule K-1 Tax Form?

  • By TurboTax
Bitcoin's Appeal Grows As More Investment Platforms Facilitate Dollar Loans Backed By Cryptocurrencies
CRYPTOCURRENCY

Why Bitcoin Won't 'Break' and Could Hit $100K: Expert Explains Crypto Boom

  • By Adam Smith
Campbell Soup May Struggle to Meet Expectations
EARNINGS

Top Earnings to Watch This Week: Campbell Soup, Oracle, Ulta

  • By Tom Bemis
10 Steps to Avoiding Tax-Return Identity Theft
Sponsored Story

What Kinds of Receipts Are Useful When Filing Taxes?

  • By TurboTax
M&A-Hungry Nestle Looking at Baby Food Maker Mead Johnson
Sponsored Story

Tax Advantages of Having a New Child

  • By TurboTax
US Senator Charles Schumer is the top Democrat in the US Senate controlled by Republicans. Democrats and Republicans have been at odds over an anti-virus package that has been valued between US$1.8 trillion to US$2.5 trillion. Photo: AFP
POLITICS

Senate Passes Biden's $1.9 Trillion Stimulus Plan

  • By Tom Bemis
New York Stock Exchange Lead
JIM CRAMER

Game Plan: Cramer's 'Mad Money' Recap (Friday 3/5/21)

  • By Scott Rutt
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.